文献速递头颈外科

人乳头瘤病毒时代对侧或双侧淋巴结的发生率

Incidence of contralateral-bilateral nodes in the human papillomavirus era.
PubMed 文献 · Laryngoscope · 2016-12-01

该回顾性队列分析纳入2001至2014年178例口咽鳞状细胞癌患者,发现HPV阳性与阴性患者对侧或双侧淋巴结转移发生率无显著差异(24.6% vs 29.1%,P = .53)。扁桃体原发灶发生率显著低于舌根(20.9% vs 34.3%,P = .048),多因素回归中肿瘤大小是唯一相关因素(T4 vs T1-3 比值比 = 5.15,95%置信区间:2.4-11.2)。

要点

  • HPV阳性与阴性患者对侧或双侧淋巴结转移发生率无显著差异(24.6% vs 29.1%,P = .53)。
  • 扁桃体原发灶对侧或双侧淋巴结转移发生率显著低于舌根(20.9% vs 34.3%,P = .048)。
  • T4分期与对侧或双侧淋巴结转移相关(T4 vs T1-3 比值比 = 5.15,95%置信区间:2.4-11.2)。

核心结论

  • HPV阳性与HPV阴性患者对侧或双侧淋巴结转移发生率无显著差异。
  • T4分期和舌根原发部位与对侧病变相关,作者认为无论HPV状态如何,这些病例可能需要对双侧颈部进行治疗。

研究设计与样本

  • 回顾性队列分析,收集2001至2014年口咽鳞状细胞癌患者数据,共178例。
  • 淋巴结状态通过增强计算机断层扫描、正电子发射断层扫描或可获得的手术病理确定。

主要发现

  • 178例患者中46例(26.0%)存在对侧或双侧淋巴结转移。
  • HPV阳性与HPV阴性患者对侧或双侧淋巴结转移发生率无显著差异(24.6% vs 29.1%,P = .53)。
  • 扁桃体原发灶对侧或双侧淋巴结转移发生率显著低于舌根(20.9% vs 34.3%,P = .048)。
  • 多因素回归中肿瘤大小是唯一与对侧或双侧淋巴结转移相关的因素(T4 vs T1-3 比值比 = 5.15,95%置信区间:2.4-11.2)。
  • 全部患者中有和无对侧或双侧淋巴结转移的5年总生存率分别为45.4%和65.2%(P = .007)。

临床怎么用

  • 作者认为,对于T4分期或舌根原发部位的病例,无论HPV状态如何,可能需要对双侧颈部进行治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: HPV-positive oropharyngeal squamous cell carcinoma has a more favorable prognosis when compared to HPV-negative disease, regardless of the presence of nodal metastases. However, the importance of contralateral neck treatment based on HPV status has not been well studied. Given the historically poor prognostic implications of cervical nodal metastases, this study sought to elucidate the relationship between HPV status and contralateral/bilateral nodal metastasis in patients with oropharyngeal squamous cell carcinoma. STUDY DESIGN: Retrospective cohort analysis. METHODS: Data were collected on patients with oropharyngeal squamous cell carcinoma from 2001 to 2014. Nodal status was determined by contrast-enhanced computed tomography, positron emission tomography, or surgical pathology when available. Survival rates and associations between HPV status and demographic/tumor characteristics were assessed. RESULTS: Of 178 total patients, 46 (26.0%) had contralateral/bilateral metastases. There was no significant difference in incidence of contralateral/bilateral nodal metastases between HPV-positive and HPV-negative patients (24.6% vs. 29.1%, P = .53). Tonsil primaries had significantly lower incidence of contralateral/bilateral nodal metastases compared to tongue base (20.9% vs. 34.3%, P = .048). On multivariate regression, tumor size was the only factor associated with contralateral/bilateral nodal metastases (T4 vs. T1-3 odds ratio = 5.15, 95% confidence interval: 2.4-11.2). Five-year overall survival among all patients with and without contralateral/bilateral nodal metastases was 45.4% and 65.2%, respectively (P = .007). CONCLUSIONS: Our results did not show a significantly different incidence of contralateral/bilateral nodal metastases between HPV-positive and HPV-negative patients. T4 stage and tongue base location, however, were associated with contralateral disease. These data suggest treatment of bilateral necks might be warranted in these cases, regardless of HPV status. LEVEL OF EVIDENCE: 4 Laryngoscope, 127:1328-1333, 2017.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Tritter AG, Mehta V, Samuelson M, et al. Incidence of contralateral-bilateral nodes in the human papillomavirus era. Laryngoscope. 2016. PMID: 27905120. doi:10.1002/lary.26439

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。